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Introduction
The prevalence of obesity is increasing dramatically worldwide with
the concomitant increase in its associated comorbidities encompassed
in the metabolic syndrome such as type 2 diabetes mellitus,
cardiovascular and non-alcoholic fatty liver disease, among others
[1-5]. In this context, normal thyroid function is necessary to maintain
body weight and a healthy metabolic profile. Current understanding of
type 2 diabetes is based on a concept of a progressive failure of
pancreatic β-cell function with concomitant increased insulin
resistance. In this regard, impaired thyroid function has been
associated with glucose intolerance by inducing hepatic
gluconeogenesis or perpetuating insulin resistance [6]. This actions are
mediated by thyroid hormone nuclear receptors (TRs), and in
particular, there are two pancreatic isoforms, located in beta-cells, that
are regulated by the thyroid, which are the TRa1 and cErb Aa2 [6-8].
Along these lines, high Thyroid-Stimulating Hormone (TSH) levels are
often observed in obese individuals and have been postulated as
possible mediators of their metabolic syndrome [8]. However, when
adjustment by other variables is made, this correlation becomes weaker
[9]. In summary, the possible role that thyroid hormones could be
playing on insulin secretion from pancreatic β-cells remains unclear
[6-8], particularly, when body composition is included in the equation
[10]. Therefore, we aimed to determine the relationship between TSH
concentrations and beta-cell function in obese subjects when
adjustment by body composition is made.
We selected 490 obese subjects >18-year-old in whom thyroid
function test and a 75 g oral glucose tolerance test (OGTT) was
performed. Insulin sensitivity and beta cell function were assessed by
OGTT-derived indexes as follows: Homeostasis model assessment of
insulin resistance (HOMA-IR), Quantitative Insulin Sensitivity Check
Index (QUICKI) and insulin sensitivity index (ISI) were used to
evaluate insulin sensitivity. In the same lines, HOMA-ß, insulinogenic
index (IGI) and disposition index (DI) were used to assess beta cell
function. Body composition study was conducted, estimating the body
density by Air-Displacement plethysmography (Bod-Pod®) and Siri
equation was used to calculate body fat percentage (BF%). Abdominal
fat content and visceral adipose tissue was determined by bioelectrical
impedance analysis using the ViScan system (Tanita Corp). Multiple
regression analysis with adjustment by age, gender, fasting plasma
glucose, BF% and %visceral fat was performed in order to identify
independent variables affecting insulin sensitivity and beta-cell
function indexes.
Mean age (SD) was 44.8 (13.7) years and mean BMI (SD) was 37.8
(7.1) kg/m2. 55.7% were women. Serum TSH was not independently
correlated with insulin sensitivity after adjustment (HOMA-IR
(ß=0.04; p=ns), ISI (ß= -0.07; p=ns), QUICKI (ß= -0.001; p=ns).
However, TSH was positively associated with pancreatic β-cell
function assessed by the DI (ß=0.338; p=0.013) and IGI (ß=0.095;
p=0.013) but not with HOMA-β (ß=1.6; p=0.716) after multivariable
adjustment.
In conclusion, within this study we found a positive relationship
between TSH and β-cell function even after adjusting by important
confounders including body fat content and distribution supporting
the potential role of thyroid hormones in the development of beta-cell
dysfunction. This association may be partly explained by the increase
in glucose-induced insulin secretion by the thyroid receptors located in
beta-cells. However, lack of significance was found when evaluating
insulin sensitivity, possibly due to the important effect that fat itself has
on the pathogenesis of insulin resistance. However, further studies are
warranted to explore in depth this relationship and underlying
mechanisms.
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